{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:39:08Z","timestamp":1792021148468,"version":"4.4.0"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1097\/crd.0000000000000026","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T17:04:12Z","timestamp":1406048652000},"page":"263-267","source":"Crossref","is-referenced-by-count":97,"title":["Prevention and Treatment In Utero of Autoimmune-Associated Congenital Heart Block"],"prefix":"10.1097","volume":"22","author":[{"given":"Amit","family":"Saxena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M","family":"Izmirly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill P.","family":"Buyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210203","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198307283090403","article-title":"Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block.","volume":"309","author":"Scott","year":"1983","journal-title":"N Engl J Med"},{"key":"R4-1-20210203","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0735-1097(02)02004-1","article-title":"Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block.","volume":"40","author":"Nield","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R5-1-20210203","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0735-1097(00)01048-2","article-title":"Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela.","volume":"37","author":"Moak","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R6-1-20210203","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/CIRCULATIONAHA.107.707661","article-title":"Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR interval and Dexamethasone evaluation (PRIDE) Prospective Study.","volume":"117","author":"Friedman","year":"2008","journal-title":"Circulation"},{"key":"R7-1-20210203","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1067\/mpd.2003.233","article-title":"Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies.","volume":"142","author":"Cimaz","year":"2003","journal-title":"J Pediatr"},{"key":"R8-1-20210203","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C","article-title":"Risk of congenital complete heart block in newborns of mothers with anti-RoSSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women.","volume":"44","author":"Brucato","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R9-1-20210203","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1002\/art.20554","article-title":"Outcome of pregnancies in patients with anti-SSARo antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group.","volume":"50","author":"Costedoat-Chalumeau","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R10-1-20210203","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/art.24768","article-title":"Recurrence rates of cardiac manifestations associated with neonatal lupus and maternalfetal risk factors.","volume":"60","author":"Llanos","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R11-1-20210203","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/CIRCULATIONAHA.107.735118","article-title":"Perinatal outcome of fetal atrioventricular block: one-hundred-sixteen cases from a single institution.","volume":"118","author":"Lopes","year":"2008","journal-title":"Circulation"},{"key":"R12-1-20210203","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/uog.1919","article-title":"Prenatal diagnosis of complete atrioventricular block associated with structural heart disease: combined experience of two tertiary care centers and review of the literature.","volume":"26","author":"Jaeggi","year":"2005","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R13-1-20210203","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0735-1097(98)00161-2","article-title":"Autoimmune-associated congenital heart block: mortality, morbidity, and recurrence rates obtained from a national neonatal lupus registry.","volume":"31","author":"Buyon","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R14-1-20210203","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jacc.2006.07.034","article-title":"Presentation and prognosis of complete atrioventricular block in childhood, according to maternal antibody status.","volume":"48","author":"Villain","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R16-1-20210203","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIRCULATIONAHA.111.033894","article-title":"Maternal and fetal factors associated with mortality and morbidity in a multi-racialethnic registry of anti-SSARo-associated cardiac neonatal lupus.","volume":"124","author":"Izmirly","year":"2011","journal-title":"Circulation"},{"key":"R17-1-20210203","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1161\/CIRCULATIONAHA.111.041970","article-title":"Isolated atrioventricular block in the fetus: a retrospective multinational, multicenter study of 175 patients.","volume":"124","author":"Eliasson","year":"2011","journal-title":"Circulation"},{"key":"R18-1-20210203","first-page":"S703","article-title":"Critical management decisions in cardiac neonatal lupus: the role of fluorinated steroids.","volume":"64","author":"Izmirly","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R19-1-20210203","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/01.CIR.0000142046.58632.3A","article-title":"Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease.","volume":"110","author":"Jaeggi","year":"2004","journal-title":"Circulation"},{"key":"R20-1-20210203","first-page":"1104","article-title":"Complete congenital heart block: risk of occurrence and therapeutic approach to prevention.","volume":"15","author":"Buyon","year":"1988","journal-title":"J Rheumatol"},{"key":"R21-1-20210203","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/art.27350","article-title":"Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study.","volume":"62","author":"Pisoni","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R22-1-20210203","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSARo-antibody-associated cardiac manifestations of neonatal lupus.","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"key":"R23-1-20210203","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1530\/eje.0.1440087","article-title":"Clinical implications of glucocorticoid metabolism by 11beta-hydroxysteroid dehydrogenases in target tissues.","volume":"144","author":"Quinkler","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"R24-1-20210203","first-page":"952","article-title":"Neonatal lupus erythematosus: results of maternal corticosteroid therapy.","volume":"93","author":"Shinohara","year":"1999","journal-title":"Obstet Gynecol"},{"key":"R25-1-20210203","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/ard.62.10.1010","article-title":"Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block.","volume":"62","author":"Costedoat-Chalumeau","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R26-1-20210203","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/BOR.0b013e328356226b","article-title":"Neonatal lupus: advances in understanding pathogenesis and identifying treatments of cardiac disease.","volume":"24","author":"Izmirly","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"R27-1-20210203","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1017\/S1047951109004053","article-title":"The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block.","volume":"19","author":"Fesslova","year":"2009","journal-title":"Cardiol Young"},{"key":"R28-1-20210203","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/0002-9378(95)90621-5","article-title":"Successful in utero therapy of fetal heart block.","volume":"173","author":"Copel","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"R29-1-20210203","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000021036","article-title":"The resolution of fetal hydrops using combined maternal digoxin and dexamethasone therapy in a case of isolated complete heart block at 30 weeks gestation.","volume":"15","author":"Brackley","year":"2000","journal-title":"Fetal Diagn Ther"},{"key":"R30-1-20210203","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1017\/S1047951103000787","article-title":"Successful management of fetal hydrops due to congenitally complete atrioventricular block.","volume":"13","author":"Sivarajah","year":"2003","journal-title":"Cardiol Young"},{"key":"R31-1-20210203","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jacc.2010.09.044","article-title":"Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy.","volume":"57","author":"Trucco","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R32-1-20210203","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1471-0528.1973.tb02126.x","article-title":"Intravenous infusion of salbutamol in the management of premature labour.","volume":"80","author":"Liggins","year":"1973","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"R33-1-20210203","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S0735-1097(10)80148-2","article-title":"Perinatal outcome of fetal complete atrioventricular block: a multicenter experience.","volume":"17","author":"Schmidt","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"R34-1-20210203","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s004040100241","article-title":"Successful prenatal treatment of congenital heart block with ritodrine administered transplacentally.","volume":"267","author":"Matsushita","year":"2002","journal-title":"Arch Gynecol Obstet"},{"key":"R35-1-20210203","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000052960","article-title":"Treatment of fetal congenital complete heart block with maternal administration of beta-sympathomimetics (terbutaline): a case report.","volume":"52","author":"Yoshida","year":"2001","journal-title":"Gynecol Obstet Invest"},{"key":"R36-1-20210203","first-page":"385","article-title":"In utero treatment of fetal complete heart block with terbutaline. A case report.","volume":"44","author":"Chan","year":"1999","journal-title":"J Reprod Med"},{"key":"R37-1-20210203","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1161\/01.CIR.92.12.3394","article-title":"Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus.","volume":"92","author":"Groves","year":"1995","journal-title":"Circulation"},{"key":"R38-1-20210203","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1017\/S1047951101001123","article-title":"Use of terbutaline in the treatment of complete heart block in the fetus.","volume":"11","author":"Robinson","year":"2001","journal-title":"Cardiol Young"},{"key":"R39-1-20210203","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3109\/14767051003728237","article-title":"A management strategy for fetal immune-mediated atrioventricular block.","volume":"23","author":"Cuneo","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R41-1-20210203","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780300106","article-title":"Intrauterine therapy for presumptive fetal myocarditis with acquired heart block due to systemic lupus erythematosus. Experience in a mother with a predominance of SS-B (La) antibodies.","volume":"30","author":"Buyon","year":"1987","journal-title":"Arthritis Rheum"},{"key":"R42-1-20210203","first-page":"134","article-title":"Myocardiopathy diagnosed in utero in a mother with SSA antibodies treated with plasmapheresis.","volume":"63","author":"Arroyave","year":"1995","journal-title":"Ginecol Obstet Mex"},{"key":"R43-1-20210203","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-2002-20947","article-title":"Intrauterine therapy and outcome in four pregnancies of one mother with anti ro-autoantibody positive Sjoegrens syndrome.","volume":"206","author":"Zemlin","year":"2002","journal-title":"Z Geburtshilfe Neonatol"},{"key":"R44-1-20210203","first-page":"666","article-title":"A combination therapy to treat second-degree anti-RoLa-related congenital heart block.","volume":"21","author":"Ruffatti","year":"2012","journal-title":"A strategy to avoid stable third-degree heart block Lupus"},{"key":"R45-1-20210203","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/00016340701343024","article-title":"Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus andor Sjogrens syndrome.","volume":"86","author":"Makino","year":"2007","journal-title":"Acta Obstetricia et Gynecologica"},{"key":"R46-1-20210203","first-page":"365","article-title":"Successful preventive treatment of congenital heart block during pregnancy in a woman with systemic lupus erythematosus and anti-Sjogrens syndrome ARo antibody.","volume":"38","author":"Yang","year":"2005","journal-title":"J Microbiol Immunol Infect"},{"key":"R47-1-20210203","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/art.27308","article-title":"Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial.","volume":"62","author":"Friedman","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R48-1-20210203","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1182\/blood.V100.6.2087","article-title":"Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia.","volume":"100","author":"Hansen","year":"2002","journal-title":"Blood"},{"key":"R49-1-20210203","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1055\/s-0037-1613331","article-title":"Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor.","volume":"88","author":"Hansen","year":"2002","journal-title":"Thromb Haemost"},{"key":"R50-1-20210203","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.291.5503.484","article-title":"Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.","volume":"291","author":"Samuelsson","year":"2001","journal-title":"Science"},{"key":"R51-1-20210203","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/art.10716","article-title":"Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al letter.","volume":"48","author":"Kaaja","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R52-1-20210203","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/AOG.0b013e3182042972","article-title":"Congenital fetal heart block: a potential therapeutic role for intravenous immunoglobulin. Author reply.","volume":"117","author":"Brucato","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R54-1-20210203","doi-asserted-by":"crossref","first-page":"30444","DOI":"10.1074\/jbc.M111.263657","article-title":"A novel role of endothelin-1 in linking Toll-like receptor 7-mediated inflammation to fibrosis in congenital heart block.","volume":"286","author":"Alvarez","year":"2011","journal-title":"J Biol Chem"},{"key":"R55-1-20210203","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2009.119263","article-title":"Evaluation of the risk of anti-SSARo-SSBLa antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine.","volume":"69","author":"Izmirly","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R56-1-20210203","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120301678646137","article-title":"Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study.","volume":"10","author":"Levy","year":"2001","journal-title":"Lupus"},{"key":"R57-1-20210203","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/art.22159","article-title":"Hydroxychloroquine in lupus pregnancy.","volume":"54","author":"Clowse","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R58-1-20210203","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/rheumatology\/41.6.643","article-title":"Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies.","volume":"41","author":"Cortes-Hernandez","year":"2002","journal-title":"Rheumatology (Oxford)"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:49:10Z","timestamp":1620949750000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045415-201411000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000026","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}